Cargando…
Translating stem cell research into development of cellular drugs—a perspective from manufacture of stem cell products and CMC considerations
The development of human pluripotent stem cell (PSC)‐derived medicinal products has been gathering steam in recent years, but the translation of research protocols into GMP production remains a daunting task. The challenges not only reside with the nature of cellular therapeutics but are also rooted...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357354/ https://www.ncbi.nlm.nih.gov/pubmed/35165957 http://dx.doi.org/10.1111/cpr.13203 |